Term
|
Definition
Trade name: dramamine
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, insomnia, itch, motion sickness
Side effects:
Heavy sedation (***) |
|
|
Term
|
Definition
Trade name: Benadryl
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, insomnia, itch, motion sickness
Side effects:
Heavy sedation (***) |
|
|
Term
|
Definition
Trade name: Atarax
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, insomnia, itch, motion sickness, vertigo, nausea, vomiting
Side effects:
Heavy sedation (***)
|
|
|
Term
|
Definition
Trade name: poly-Histine-D
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, motion sickness, vertigo, nausea, vomiting
Side effects:
Moderate sedation (**)
|
|
|
Term
|
Definition
Trade name: Phenergan
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Insomnia, motion sickness, anti-emetic
Side effects:
Heavy sedation (***) |
|
|
Term
|
Definition
Trade name: perlactin
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, migraine, Cushing's syndrome
Side effects:
Moderate sedation (**)
|
|
|
Term
|
Definition
Trade name: Dimetapp
Mechanism of action:
1st generation H1 receptor antagonist
Clinical Use:
Allergy, common cold, rhinitis, potentiate analgesia
Side effects:
LOW sedation (*)
|
|
|
Term
|
Definition
Trade name: Allegra
Mechanism of action:
2nd generation H1 receptor antagonist
Clinical Use:
Allergy, insomnia, itch, motion sickness, potentiate opioid analgesia
Side effects:
NON-sedating
|
|
|
Term
|
Definition
Trade name: Allegra
Mechanism of action:
2nd generation H1 receptor antagonist
Clinical Use:
Allergy, insomnia, itch, motion sickness, potentiate opioid analgesia
Side effects:
NON-sedating
|
|
|
Term
Omeprazole (Prilosec®)
Lansoprazole (Prevacid®)
Rabeprazole (AcipHex®)
Pantoprazole (Protium®)
Esomeprazole (Nexium®)
|
|
Definition
Class of drug:
Proton pump inhibitors in parietal cell (irreversible) --> have to synthesize new pump
Mechanism of action:
Taken as a prodrug --> acid resistant capsule (acid labile drugs) --> dissolve in intestinal lumen --> absorbed --> released where gastrin/somatostatin are released --> protonated in canaliculi --> bind channel and exert action
Clinical Use:
heartburn, GERD, peptic ulcer from NSAID or H. pylor
Side effects:
Vitamin B12 deficiency, Ca2+, Iron and zinc absorption issues. Take a supplement with them.
|
|
|
Term
|
Definition
Class of drug:
Mucosal protective agent (use with PPI or H1 antagonist)
Mechanism of action:
Reacts with HCl in stomach --> forms viscous paste & acid buffer --> complexes with albumin/fibrinogen creating protective barrier
Clinical Use:
gastric/dudenal ulcers, stress related GI bleeding
Side effects:
Constipation, flatulence
|
|
|
Term
|
Definition
Class of drug:
Mucosal protective agent (use with PPI or H1 antagonist)
Mechanism of action:
PGE1 analogue --> increases mucus/bicarbonate secretion, increase mucosal blood flow (activates PG-E3/E4 receptors on parietal cells --> Gi -->decrease cAMP --> counter histamine effects
Clinical Use:
NSAID induced ulcers, gastric/dudenal ulcers using NSAIDs
Side effects:
Diarrhea, abdominal pain
|
|
|
Term
|
Definition
Class of drug:
Bismuth protective antacid
Mechanism of action:
Unknown, but decreases inflammation and irritation of GI lining via protective coat action
Clinical Use:
H. pylori cocktail, dyspepsia, acute diarrhea
Side effects:
Black tongue/stools; Reyes Syndrome
|
|
|
Term
|
Definition
Class of drug:
Pro-kinetic agent
Mechanism of action:
5-HT4 receptor antagonist --> ACh release in myenteric plexes --> stimulate gastric emtying.
It also inhibits D2 receptor (blocks ACh release)
Clinical Use:
GERD, IBS syndrome, gastritis, dyspepsia
Side effects:
Significant CNS effects (D2 is site for antisychotic drugs)
|
|
|
Term
Cimetidine (Tagament)
Ranitidine (Zantac)
Famotidine (Pepcid)
Nizantidine (Axid) |
|
Definition
Class of drug:
H2 receptor antagonists
Mechanism of action:
Blocks H2 receptor on the parietal cell --> no signal to increase HCl secretion
Clinical Use:
heartburn, GERD, peptic/gastric ulcers, stress related GI bleeding
Side effects:
Diarrhea, headache, fatigue, myalgias, constipation, gynecomastia at high concentrations --> increased estradiol effects
Potency:
famotidine > nizatidine =ranitidine > cimetidine
|
|
|
Term
|
Definition
1. Parietal cell --> secretes HCL in response to H2 binding (little also in response to ACh from vagus)
2. Enterochromaffin-like cell --> secretes Histamine onto parietal cell
3. G-cell --> in response to food in stomach secretes gastrin --> through antrum/fundis blood vessels --> gastrin binds receptor on ECC --> H2 release
4. D-cell --> releases somatostatin --> acts on G cell & stops gastrin release, aslo enters blood vessel and acts on ECC --> prevents H+ secretion
Acetylcholine can also activate --> ACh --> M3 on ECC (that releases histamine) and on parietal cell --> HCl release |
|
|
Term
|
Definition
Acute:
1. Beta2 agonists
2. Muscarinic antagonists
3. Theophylline
Chronic:
1. Long-acting Beta2 (improve response to steroids)
2. Corticosteroids
3. Inhibitors of mast cell mediator release
4. Anti-IgE antibodies
Prophylaxis:
1. Leukotriene antagonists |
|
|